nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.
nChroma Bio has raised $75.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
nChroma Bio's investors include Menlo Ventures, ARCH Venture Partners, Cormorant Asset Management, Mubadala Capital, Janus Henderson Investors.
nChroma Bio is headquartered in Boston, United States.
nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.
nChroma Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"nChroma Bio — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/nchroma-bio. Accessed July 19, 2026.
VCBacked. (2024). nChroma Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/nchroma-bio
{{cite web |title=nChroma Bio — Funding & Investors |url=https://www.vcbacked.co/company/nchroma-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated